Campbells of Campbell Alliance step aside for new CEO
This article was originally published in Scrip
Campbell Alliance, an inVentiv Health consulting firm specialising in the pharmaceutical and biotech industries, has appointed Nader Naeymi-Rad chief executive officer, succeeding John Campbell who co-founded the firm. John Campbell and Ann Campbell, who is currently president of the company, will co-lead a committee of the Campbell Alliance board of directors, focusing on strategic growth opportunities abroad. Mr Naeymi-Rad has served the company since 1997 when it was founded, most recently as chief operating officer.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.